{"@id":"https://bioecon.ru/technology/geroprotector-repurposing-rapamycin-metformin-tame/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/geroprotector-repurposing-rapamycin-metformin-tame/","json":"https://cn.bioecon.ru/api/v1/technology/geroprotector-repurposing-rapamycin-metformin-tame/index.json"},"id":"geroprotector-repurposing-rapamycin-metformin-tame","industries":["longevity"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/longevity/"],"suppliers":["https://bioecon.ru/companies/vinaseed/","https://bioecon.ru/companies/milwhite-inc/","https://bioecon.ru/companies/bioviva/","https://bioecon.ru/companies/pivot-bio/","https://bioecon.ru/companies/mustgrow-biologics-corp/"]},"maturity":4,"name":"老药新用抗衰老试验（雷帕霉素、二甲双胍、TAME）","regions":["us","eu"],"risk":"high","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-09","entity":"onlinelibrary.wiley.com","kind":"research","urls":["https://onlinelibrary.wiley.com/doi/10.1111/acel.13596"]},{"date":"2026-11-09","entity":"pmc.ncbi.nlm.nih.gov","kind":"research","urls":["https://pmc.ncbi.nlm.nih.gov/articles/PMC6428447/","https://pmc.ncbi.nlm.nih.gov/articles/PMC5055653/","https://pmc.ncbi.nlm.nih.gov/articles/PMC12486172/"]},{"date":"2026-11-09","entity":"ncbi.nlm.nih.gov","kind":"research","urls":["https://ncbi.nlm.nih.gov/pmc/articles/PMC10643772/"]}],"stages":[{"n":1,"title":"与监管方沟通"},{"n":2,"title":"设计试验"},{"n":3,"title":"遴选候选药物"},{"n":4,"title":"确定终点"}],"summary":"已获批药物被作为抗衰老干预进行试验；TAME二甲双胍试验处于规划阶段，雷帕霉素处于早期试验，FDA与EMA尚未承认衰老结局可作为批准路径。","url":"/technology/geroprotector-repurposing-rapamycin-metformin-tame/","verified":"2026-11-09"}